218 related articles for article (PubMed ID: 38203379)
1. Qualification of the Microsatellite Instability Analysis (MSA) for Bladder Cancer Detection: The Technical Challenges of Concordance Analysis.
Reynolds T; Bertsche K; Moon D; Moon C
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203379
[TBL] [Abstract][Full Text] [Related]
2. Microsatellite Instability Analysis (MSA) for Bladder Cancer: Past History and Future Directions.
Moon C; Gordon M; Moon D; Reynolds T
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884669
[TBL] [Abstract][Full Text] [Related]
3. Results Obtained from a Pivotal Validation Trial of a Microsatellite Analysis (MSA) Assay for Bladder Cancer Detection through a Statistical Approach Using a Four-Stage Pipeline of Modern Machine Learning Techniques.
Reynolds T; Riddick G; Meyers G; Gordon M; Flores Monar GV; Moon D; Moon C
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203643
[TBL] [Abstract][Full Text] [Related]
4. [Microsatellite instability in urine sediments from patients with transitional cell carcinoma of bladder and its clinical value].
Lü Y; Tang D; Yu L; Ding Y; Liu L; Guo Y
Zhonghua Wai Ke Za Zhi; 2000 Apr; 38(4):294-6. PubMed ID: 12828175
[TBL] [Abstract][Full Text] [Related]
5. Sensitive detection of transitional cell carcinoma of the bladder by microsatellite analysis of cells exfoliated in urine.
Seripa D; Parrella P; Gallucci M; Gravina C; Papa S; Fortunato P; Alcini A; Flammia G; Lazzari M; Fazio VM
Int J Cancer; 2001 Nov; 95(6):364-9. PubMed ID: 11668518
[TBL] [Abstract][Full Text] [Related]
6. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.
Bartoletti R; Dal Canto M; Cai T; Piazzini M; Travaglini F; Gavazzi A; Rizzo M
Oncol Rep; 2005 Mar; 13(3):531-7. PubMed ID: 15706429
[TBL] [Abstract][Full Text] [Related]
7. Assessment of microsatellite instability in urine in the detection of transitional-cell carcinoma of the bladder.
Mourah S; Cussenot O; Vimont V; Desgrandchamps F; Teillac P; Cochant-Priollet B; Le Duc A; Fiet J; Soliman H
Int J Cancer; 1998 Dec; 79(6):629-33. PubMed ID: 9842973
[TBL] [Abstract][Full Text] [Related]
8. Development of Multiplex Polymerase Chain Reaction (PCR)-Based MSA Assay for Bladder Cancer Detection.
Reynolds T; Gordon M; Monar GVF; Moon D; Moon C
Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686456
[TBL] [Abstract][Full Text] [Related]
9. [Microsatellite analysis in exfoliated cells from urinary sediment. Its utility for the detection of bladder cancer. Comparison with urinary cytology].
Molina Burgos R; Millán Salvador JM; Oltra Soler JS; Jiménez Cruz JF
Actas Urol Esp; 2003 Sep; 27(8):618-28. PubMed ID: 14587237
[TBL] [Abstract][Full Text] [Related]
10. A Novel Urine-Based Assay for Bladder Cancer Diagnosis: Multi-Institutional Validation Study.
Davis N; Shtabsky A; Lew S; Rona R; Leibovitch I; Nativ O; Cohen M; Mor Y; Lindner U; Glickman Y; Matzkin H; Tsivian A; Gofrit O; Yossepovitch O
Eur Urol Focus; 2018 Apr; 4(3):388-394. PubMed ID: 28753799
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer.
Sarosdy MF; Schellhammer P; Bokinsky G; Kahn P; Chao R; Yore L; Zadra J; Burzon D; Osher G; Bridge JA; Anderson S; Johansson SL; Lieber M; Soloway M; Flom K
J Urol; 2002 Nov; 168(5):1950-4. PubMed ID: 12394683
[TBL] [Abstract][Full Text] [Related]
12. Microsatellite alterations in human bladder cancer: detection of tumor cells in urine sediment and tumor tissue.
Berger AP; Parson W; Stenzl A; Steiner H; Bartsch G; Klocker H
Eur Urol; 2002 May; 41(5):532-9. PubMed ID: 12074795
[TBL] [Abstract][Full Text] [Related]
13. A Prospective Blinded Evaluation of Urine-DNA Testing for Detection of Urothelial Bladder Carcinoma in Patients with Gross Hematuria.
Dahmcke CM; Steven KE; Larsen LK; Poulsen AL; Abdul-Al A; Dahl C; Guldberg P
Eur Urol; 2016 Dec; 70(6):916-919. PubMed ID: 27417036
[TBL] [Abstract][Full Text] [Related]
14. Genomic instability analysis of urine sediment versus tumor tissue in transitional cell carcinoma of the urinary bladder.
Turyn J; Matuszewski M; Schlichtholz B
Oncol Rep; 2006 Jan; 15(1):259-65. PubMed ID: 16328066
[TBL] [Abstract][Full Text] [Related]
15. Non-invasive molecular detection of bladder cancer recurrence.
Amira N; Mourah S; Rozet F; Teillac P; Fiet J; Aubin P; Cortesse A; Desgrandchamps F; Le Duc A; Cussenot O; Soliman H
Int J Cancer; 2002 Sep; 101(3):293-7. PubMed ID: 12209982
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of a comprehensive, urothelial carcinoma-specific next-generation sequencing panel in urine cytology and bladder tumor specimens.
Sun T; Hutchinson L; Tomaszewicz K; Caporelli ML; Meng X; McCauley K; Fischer AH; Cosar EF; Cornejo KM
Cancer Cytopathol; 2021 Jul; 129(7):537-547. PubMed ID: 33539671
[TBL] [Abstract][Full Text] [Related]
17. Development of a 90-Minute Integrated Noninvasive Urinary Assay for Bladder Cancer Detection.
Wallace E; Higuchi R; Satya M; McCann L; Sin MLY; Bridge JA; Wei H; Zhang J; Wong E; Hiar A; Mach KE; Scherr D; Egerdie RB; Ohta S; Sexton WJ; Meng MV; Weizer AZ; Woods M; Jansz GK; Zadra J; Lotan Y; Goldfarb B; Liao JC
J Urol; 2018 Mar; 199(3):655-662. PubMed ID: 29061538
[TBL] [Abstract][Full Text] [Related]
18. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer.
Dalbagni G; Han W; Zhang ZF; Cordon-Cardo C; Saigo P; Fair WR; Herr H; Kim N; Moore MA
Clin Cancer Res; 1997 Sep; 3(9):1593-8. PubMed ID: 9815848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]